Pathological fractures in primary malignant bone tumours.
D000818:Animals; D001706:Biopsy; D001859:Bone Neoplasms / Q000145:classification / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D002146:Bony Callus / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D050723:Fractures, Bone / Q000628:therapy; D005598:Fractures, Spontaneous / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control / Q000628:therapy; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D008979:Moloney murine leukemia virus; D009101:Multiple Myeloma / Q000628:therapy; D012516:Osteosarcoma / Q000150:complications; D011379:Prognosis; D012513:Sarcoma, Experimental / Q000150:complications; D013124:Spinal Injuries / Q000628:therapy
D006728:Hormones; D003520:Cyclophosphamide